Yonsei Cancer Center, Yonsei Univ. College of Medicine
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sohn, Joohyuk
NCT05207514: Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Terminated
3
26
RoW
Nanoxel M, polysorbate 80, ethanol free docetaxel, Taxotere, docetaxel, Doxorubicin, Cyclophosphamide
Samyang Biopharmaceuticals Corporation
Breast Cancer
02/24
05/24
NCT04946227: Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')

Not yet recruiting
2
52
RoW
Pembrolizumab 200mg +Paclitaxel 80mg/m2
Yonsei University
Breast Cancer
12/22
12/22
KCSG BR21-10, NCT04755868: Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

Not yet recruiting
2
206
RoW
Talazoparib, Placebo
Yonsei University
TNBC - Triple-Negative Breast Cancer
03/24
03/24
Decrescendo, NCT04675827: De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade

Terminated
2
139
Europe, RoW
Pertuzumab and tratuzumab fixed dose combination, Adjuvant pertuzumab + trastuzumab FDC SC for 14 cycles, Fixed-dose combination of Perjeta and Herceptin for subcutaneous injection for 14 cycles, Trastuzumab emtansine, Adjuvant T-DM1
Jules Bordet Institute, Breast International Group, Hoffmann-La Roche, International Drug Development Institute, Institut Curie
HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer, Node-negative Breast Cancer
11/24
11/24
ENZENO, NCT04669587: ER+/HER2- Locally Advanced or Metastatic Breast Cancer ( Study)

Recruiting
1/2
106
US, RoW
ZB716, Borestrant, Palbociclib, Ibrance®
EnhancedBio USA Inc., Zenopharm
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer, Metastatic Breast Cancer
01/23
01/24
ELVN-002-003, NCT06328738: ELVN-002 with Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

Recruiting
1
275
Europe, US, RoW
ELVN-002, Trastuzumab, 5-Fluorouracil, Oxaliplatin, Capecitabine, Eribulin, paclitaxel, Leucovorin
Enliven Therapeutics
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification, Colorectal Cancer
01/27
07/28
NCT06231953: A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers

Recruiting
N/A
4000
RoW
Yonsei University
Invasive Cancer, Healthy Volunteer
12/26
12/26

Download Options